Works matching IS 10015302 AND DT 2024 AND VI 49 AND IP 3


Results: 31
    1
    2

    中成药上市后临床有效性研究指南.

    Published in:
    China Journal of Chinese Materia Medica, 2024, v. 49, n. 3, p. 842, doi. 10.19540/j.cnki.cjcmm.20231013.501
    By:
    • 王志飞;
    • 谢雁鸣;
    • 唐健元;
    • 张俊华;
    • 孙鑫;
    • 杨忠奇
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    基于代谢组学的六神曲降血脂作用机制研究.

    Published in:
    China Journal of Chinese Materia Medica, 2024, v. 49, n. 3, p. 770, doi. 10.19540/j.cnki.cjcmm.20231019.401
    By:
    • 刘金辉;
    • 田颖颖;
    • 赵新月;
    • 李依林;
    • 吕英楠;
    • 刘闯;
    • 林兆洲;
    • 王子健;
    • 左泽平;
    • 王志斌
    Publication type:
    Article
    10
    11
    12
    13

    稀花八角枫的化学成分研究.

    Published in:
    China Journal of Chinese Materia Medica, 2024, v. 49, n. 3, p. 735, doi. 10.19540/j.cnki.cjcmm.20231109.202
    By:
    • 金倩倩;
    • 杨婷;
    • 朱敏汇;
    • 张美秦;
    • 汪洋;
    • 潘洁;
    • 王永林;
    • 李勇军
    Publication type:
    Article
    14

    凉粉草中2个新的倍半萜苯甲酰酯.

    Published in:
    China Journal of Chinese Materia Medica, 2024, v. 49, n. 3, p. 728, doi. 10.19540/j.cnki.cjcmm.20231019.201
    By:
    • 陈雅丽;
    • 王紫琴;
    • 宋建国;
    • 黄晓君;
    • 唐维;
    • 叶文才;
    • 王英
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    方剂组学高质量发展要义.

    Published in:
    China Journal of Chinese Materia Medica, 2024, v. 49, n. 3, p. 569, doi. 10.19540/j.cnki.cjcmm.20231010.601
    By:
    • 王永炎;
    • 王忠
    Publication type:
    Article